Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC

ClinicalTrials.gov ID: NCT04844983

Public ClinicalTrials.gov record NCT04844983. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to evaluate safety, tolerability and efficacy of various doses of STP705 administered as intralesional injection in subjects with cutaneous squamous cell carcinoma (in situ) skin cancer (isSCC).

Study identification

NCT ID
NCT04844983
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sirnaomics
Industry
Enrollment
44 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 18, 2021 (Actual)
Primary completion
Aug 24, 2022 (Actual)
Completion
Dec 6, 2022 (Actual)
Last update posted
Mar 18, 2024

2021 – 2022

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Investigate MD Scottsdale Arizona 85255 —
Center for Clinical and Cosmetic Research Aventura Florida 33180 —
Research Institute of the Southeast LLC West Palm Beach Florida 33401 —
Dermatology, Laser and Vein Specialists of the Carolinas Charlotte North Carolina 28207 —
Dermatology Associates of Knoxville Knoxville Tennessee 37909 —
Tennessee Clinical Research Nashville Tennessee 37215 —
Austin Institute for Clinical Research Pflugerville Texas 78660 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04844983, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 18, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04844983 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →